The availability to the DNA strand and the activity of the transcription machinery is crucial for the cell to use the information in the DNA. The epigenetic mechanisms DNA methylation, modification of histone tails, other chromatin-modifying processes and interference by small RNAs regulate the cell-type-specific DNA expression. Epigenetic marks can be more or less plastic perpetuating responses to various molecular signals and environmental stimuli, but in addition apparently stochastic epigenetic marks have been found. There is substantial evidence from animal and man demonstrating that both transient and more long-term epigenetic mechanisms have a role in the regulation of the molecular events governing adipogenesis and glucose homeostasis. Intrauterine exposure such as poor maternal nutrition has consistently been demonstrated to contribute to a particular epigenotype and thereby developmental metabolic priming of the exposed offspring in animal and man. Epigenetic modifications can be passed not only from one cell generation to the next, but metabolic disease-related epigenotypes have been proposed to also be transmitted germ-line. Future more comprehensive knowledge on epigenetic regulation will complement genome sequence data for the understanding of the complex etiology of obesity and related disorder.
Introduction
Generally, the identification of genetic vulnerability factors accounting for the estimated heritability in complex multifactorial diseases, such as most cases of obesity and metabolic syndrome, has been less successful than expected. 1 One reason could be that only the DNA sequence is considered but not the extent to which the actual sequence is expressed. The information about gene expression regulation is covered by epigenetics. Epigenetics may also provide molecular mechanistic explanations for the well-defined environmental effects on phenotypes and their plasticity. Therefore, mapping the epigenome is potentially as important as the mapping of the genome in our quest to understand phenotypic differences in humans. 2 Epigenetics was originally defined as 'heritable changes that regulate gene expression that occur without a change in the nucleotide sequence' (for review, see Bird 3 ), and recently defined as 'any long-term change in gene function that persists even when the initial trigger is long gone that does not involve a change in gene sequence or structure'. 4 Epigenetic modifications can be passed from one cell generation to the next (mitotic inheritance) and may be passed between generations (meiotic inheritance) 5, 6 (for review, see Gluckman et al. 7 ), although the evidence of true transgenerational epigenetic inheritance (that is, to the F3 generation since primordial germ cells (becoming F2) of the offspring (F1) may be affected in utero of F0) is limited in mammals because of robust prenatal genome-wide epigenetic reprogramming. The dynamics of epigenetics make it possible to respond reversibly to environmental cues, but also to firmly cement cell-type-specific gene programs. Thus, epigenetic marks can be more or less stable. 8 There is a high degree of complexity of epigenetic processes during prenatal and early postnatal development. The epigenetic profile (landscape) is established early and may make an imprint that is sustained throughout life, to maintain the diverse gene expression patterns of different cell types, and indeed individuals. The prenatal environment affects these epigenetic conductors of the embryo development. Such prenatal effects have been shown to influences the adult life. The epigenetic profiles are also sensitive to the environment in childhood and adult life. 9 Epigenetic factors include those that affect the ability to regulate the gene transcription process. Such regulation of gene expression also relies on the accessibility of the DNA to various transcription factors, coactivators/corepressors, and the transcriptional machinery. The genomic DNA in eukaryotic cells exist as the physical structure chromatin. Chromatin is the array of histone-containing nucleosomes, where each nucleosome consists of DNA wrapped around an octamer of histones (usually two each of H2A, H2B, H3, H4 and one linker histone H1). Apart from the binding of transcription factors to their cognate promoter cis-acting elements, transcriptional activation or repression is also dependent on the recruitment of protein complexes that alter chromatin structure. Therefore, alterations of gene transcription and repression depend on a chromatin structure that is very dynamic. Epigenetic mechanisms include DNA methylation, and chromatin modification processes such as histone tail modifications. Methylation of DNA in conjunction with modifications of histone proteins such as acetylation and methylation can regulate the binding of transcription regulators and provide poised states that allow for future activation or silenced genes. This will be discussed further down.
Methylation of DNA
In mammals, DNA methylation occurs at cytosines primarily in CpG dinucleotides (5-methyl cytosine, 5mC). DNA methylation in promoter regions is often associated with transcriptional silencing achieved by repressing the binding of transcription factors or by recruiting 5mC-binding proteins (MBD1, MBD2 and MBD3) that initiate the formation of compact heterochromatin in part by interacting with histone-modifying enzymes. 10 The major enzymes involved in establishing and maintaining this 5-mC patterns are the DNA methyltransferases (DMNT) 3a and DNMT3b, which add methyl-groups de novo, 11 and DNMT1 that ensures that methylation patterns are copied faithfully throughout each cell division. 12 CpG dinucleotides are unevenly distributed in the genome and the majority is maintained in a methylated state. 13 However, CpG-rich regions, called CpG islands, are often unmethylated in normal cells. Exceptions to this are methylated CpG islands on the inactive X-chromosome. The CpG islands are often found in the 5 0 region of genes including the promoter. There are reports supporting that methylation in these CpG islands regulates gene expression, and that tissue-specific methylation in those provides tissue-specific expression patterns. [14] [15] [16] However, often the regulation is more complex because there are CpG sites in regulatory regions outside the promoters, and the involvement of modification of the chromatin structure. In fact, the degree of methylation of cytosines 1-2 kb downstream or upstream the islands, so called 'shores', have been found to associate strongly to cell type and to disease, with the shores containing B80% of the regions with tissuespecific methylation. 17 Although recent reports support the importance of cytosine methylation in both shore and repeat regions, 18 cytosine methylation has primarily been studied in gene promoters because they are known to be central in regulation of transcription. The mechanism leading to loss of DNA methylation is still disputed. 20 The dynamic nature of DNA methylation is illustrated by the age-dependent progression of epigenetic changes suggested by larger differences in global DNA methylation patterns in older pairs than younger pairs of monozygotic twins. 21, 22 The recent discovery of hydroxylation of methylcytosine leading to 5-hydroxymethylcytosine (5hmC) has added yet another complexity to the epigenetic mechanisms. 23, 24 5hmC is present in mammalian DNA at physiologically relevant levels and in a tissue-specific manner. 25 
Modification of histone proteins
Many of the amino acid residues in the histone N-terminals can be modified by histone-modifying enzymes, resulting in modifications such as acetylation, methylation, phosphorylation to name a few (for review, see Kouzarides 28 ). Acetylation of histones is generally associated with active gene transcription. Histone acetyl transferases are those that add acetyl groups to lysine residues on histone tails. Most histone acetyl transferases have low specificity, being able to modify numerous lysine residues on both histone and nonhistone proteins. Consequently, removal of acetyl group from a histone residue by histone deacetylases (HDACs) represses gene transcription. HDACs are found to be components of repressor complexes and to be involved in various signaling pathways (for review, see Haberland et al. 29 ). The precise mode of action of the modified histone tails is not known yet. However, positive charges of lysine Epigenetic regulation in obesity C Lavebratt et al tails are neutralized by acetylation causing the attraction between DNA and histones to weaken, resulting in opening of chromatin structure. An alternative hypothesis to the functionality of histone tail modifications is that specific proteins recognize and interact with the histone modifications. Overall, histone acetylation can occur quite rapidly and is quite dynamic. Other modifications of histones, such as methylation, can be either activating or repressing depending on degree of modification and specific site of the modification (for review, see Zhou et al. 30 ). Importantly, the DNMTs also interact with histone-modifying proteins in a complex regulatory network. In addition, cross-talk mechanisms have also been suggested where specific histone modifications can facilitate or block additional histone marks resulting in multiple histone modifications acting in concert to regulate transcription. Histone modifications could precede or succeed DNA methylation. It is unknown to what extent histone modifications initiate or simply maintain the transcriptional memory, but they can maintain a signal from a transcription factor/repressor even after this factor has left the DNA. 31 
Small RNAs
The recently discovered group of small RNAs or microRNAs (miRs) provides a rapid reversible regulation of gene expression. miRs are short, B20-30-nucleotides long noncoding RNAs that normally bind the 3 0 -untranslated region of target mRNAs, leading to either post-transcriptional silencing and translational repression or RNA degradation. 32 Hence, these small RNAs provide means for the cell to quickly respond to environmental stimuli. There is also the potential for miRNAs to target chromatin-modifying enzymes, resulting in epigenetic modifications affecting gene expression. Additionally, histone modifications and changes in chromatin structure can affect transcription and expression of miRNAs. 33 The miRBase database provides a searchable online repository for published miR sequences (http:// www.mirbase.org).
Tissue-specificity in epigenetic patterns
The DNA methylation, histone modifications, small inhibitory RNAs and other chromatin remodeling proteins act in combination to alter chromatin accessibility, structure and function. When combining the possible modifications of the histones at specific amino acids at specific times the possible combinations may be astronomical. To this complexity is added DNA-methylation, which is intimately involved with the histone modifications, and small regulating RNAs. When instability of epigenetic marks is created, disease might arise. Historically, cancer was the first category in focus for genespecific disease epigenetics, 34 as well as for genome-wide disease epigenetics. 35 Both DNA methylation changes and histone modifications have been found to be widespread in cancer. 36 Differentially methylated regions in DNA (DMRs) have been shown to associate with normal cell phenotype, and alterations of DMRs with cancer cells. Interestingly, DMRs in subsets of genes associated with a particular cancer cell type were also found in specific normal tissues. 17, 37 Several of the DMRs common to both cancer cells and normal tissues, are located in the vicinity to developmentally important genes. Hence, these DMRs may constitute regulatory regions of these genes. 17 Individual stochastic variation versus genetic predisposition of epigenetic pattern This could be through DNA sequence variation in CG-sites, or small-RNA target sites in coding genes. Also, there may be DNA sequence variation in peptides in the epigenetic machinery, which could affect the outcome of the functional genome. Epigenetic influences that may alter gene expression are therefore sensitive not only to environment and chance, but also to the genetic make-up. The DNA sequence variation may hence affect both the stochastic and environmentally influenced variance in the epigenome ( Figure 1 ). 8 We here review some of the findings on epigenetic regulation in the etiology and development of obesity.
• Diet ), genotype and epigenotype all regulate phenotype, in synergy or alone. The dynamic epigenotype provides plasticity of the phenotype. Regions with apparent stochastic epigenetic patterning have also been reported.
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Epigenetic factors in obesity
The research in epigenetics has increased exponentially during the last few years. Gene-specific epigenetic marks have been associated to diseaseFalso obesityFand related conditions. The vast majority of studies have focused on methylation of CpG islands (CpG-rich site) in gene promoters. A functional hypermethylation of normally unmethylated CpGs in gene promoters would correlate with transcriptional repression.
CpG methylation has a role in the regulation of adipogenesis and glucose homeostasis. Tissue-specific level of CpG methylation is found for example in promoters of leptin, pro-opiomelanocortin (precursor for melanocyte-stimulating hormone (a-MSH), ACTH and b-endorphine) and insulin correlating to the corresponding tissue-specific expression levels (for review, see McAllister). 39, 40 That changes in DNA methylation can occur postnatally can be exemplified by increase in CpG methylation of the key metabolic transcriptional regulator peroxisome proliferator-activated receptor-a (Ppar-a) by folate supplementation in young rodents. 41 In fact, mice on high-fat diet developed hypomethylation in the satiety-receptor melanocortin-4 receptor, 42 whereas neonatal overfeeding rats, and rats obese because of overfeeding in small litters, developed hypermethylation of the satiety-mediator pro-opiomelanocortin in hypothalamus. 43 The promoter of glucose transporter 4 was reported demethylated at adipocyte differentiation, and its methylation could inhibit nuclear factor binding to the promoter. 44 Also the Pparg2 promoter was demethylated upon induction of adipocyte differentiation correlating with expression, and it was hypermethylated at one CpG in the visceral adipose tissue of genetically induced and diet-induced obese mice. 45 Further, the PPAR-g proteins interact with histone methyltransferases during adipogenesis, 46 thereby regulating the transcription of other genes. Moreover, FTO that is genetically associated with obesity and type 2 diabetes, is a DNAdemethylase. 47 Deficiency in the histone demethylase Jhdm2a has been implicated in obesity, through its proposed action in the regulation of Ppara and b-adrenergic signaling pathways through modifying lysine 9 on H3 (H3K9). 48 CpG methylation level at a specific allele of a single-nucleotide polymorphism in melanin-concentrating hormone receptor 1 exon 1 was recently shown to associate to body mass index in peripheral blood mononuclear cell from young adults. This may in part explain previous contradictory results on genetic association for this single-nucleotide polymorphism to obesity. 49 In addition, a list of genes with reported variation in DNA methylation in promoter CpG islands, most detected in cancer, but with a biological function related to adipogenesis, inflammation, fat metabolism and insulin signaling, are reported by Campió n et al. 50 Importantly, CpGs outside CpG islands, in promoters and elsewhere, and cytosines in non-CpG sites, have also been found to have variation in DNA methylation associated to metabolism-related phenotype. In fact, methylation of cytosine in non-CpG sites of PPARg coactivator-1a has been associated to type 2 diabetes. 51 Also, there are miRNAs associated with the regulation of genes relevant to insulin secretion, cholesterol biosynthesis, fat metabolism and adipogenesis (reviewed by Heneghan et al. 52 ). There are several genome-wide studies reporting miRNAs being differentially regulated in differentiated compared with undifferentiated cells from animal-derived adipocytic lineages. 53 Recently, human miRNAs regulated differentially in adipose cells (preadipocytes and mature adipocytes) from obese individuals compared with lean individuals have been reported from a genome-wide study. This revealed also remarkably different miRNA profile between preadipocytes and mature adipocytes. Further, miRNAs from subcutaneous adipose tissue associated with adipose tissue physiology, glucose metabolism and/or obesity status were reported. 54 Whether DNA methylation can change over time or not has been discussed. There are reports suggesting that DNA methylation changes over time and mediates environmental effects on human disease. 55 Other studies support that DNA methylation patterns are likely quite stable over time but variable between individuals as a result of inheritance. 56 Feinberg et al. 57 have recently reported genome-wide human epigenetic data from peripheral blood mononuclear cells demonstrating 227 regions (VMRs) that showed variability in DNA methylation level between 74 elderly persons. About 50% of those VMRs remained stable within the person over 11 years whereas the rest of the VMRs changed over time. This supports that there are stable epigenetic marks, possibly governed by genetics, and non-stable epigenetic marks possibly influenced by environment. The stable VMRs can be used as an epigenetic signature for an individual, similar to genotype. These stable VMRs can be used as candidates for assessment of non-environmental DNA-methylation associations with disease or phenotype and hence predisposing variants of disease. In fact, four of the stable epigenetic marks were correlated with body mass index at two time points 11 years apart. They resided in or nearby the genes MMP9, PM20D1, PRKG1 and RFC5. MMP9 and PM20D1 are metalloproteinases. MMPs (including MMP9) are known to be upregulated in human adipocytes, 58 and have been associated with obesity in rodent models. 59, 60 PRKG1, a guanosine 3 0 ,5 0 -monophosphate (cGMP)-dependent protein kinase is important in regulating foraging behavior, food acquisition and energy balance. 61 RFC5 is a metabolism-linked DNA replication complex loading protein, dysfunction of which leads to DNA repair defects. Genomic imprinting, that is, the epigenetic mechanism that regulates parent of origin-specific expression of a subset of genes, is implicated in some obesity cases. The majority of Prader Willi syndrome cases with obesity are due to deletion in an imprinted locus on the paternal chromosome 15. As the maternal corresponding locus is epigenetically silenced it cannot compensate for the deletion. 62 Also, imprinted genetic variants will be penetrant only if inherited Epigenetic regulation in obesity C Lavebratt et al from the non-silenced allele, as seems to be the case for the obesity-associated polymorphism class I VNTR in the insulin gene. 63 
Developmental priming of obesity
There is substantial evidence in humans and animal models demonstrating that epigenetic mechanisms during development in utero sometimes are affected by dietary factors in the mother and could be involved in obesity susceptibility in the offspring. Epigenetic marks induced by the developmental environment are in agreement with the 'developmental plasticity' hypothesis, 64 that is, that the organism has an ability to undergo metabolic alterations during early development in order to match the phenotype to the anticipated future environment. High-fat diet, caloric restriction or protein restriction developmental priming for components in the metabolic syndrome has been seen from both maternal and paternal origin in man and animal models (reviewed by Bruce and Cagampang 65 ). For example, children born after maternal weight loss through bariatric surgery had a lower risk for obesity than did their siblings born before maternal weight loss, 66 and paternal high-fat exposure primes pancreatic b-cell dysfunction in rodent offspring (F1), leading to early onset of progressive impaired insulin secretion and glucose tolerance. 67 Prenatal exposure to excess testosterone have been shown to induce a syndrome similar to polycystic ovary syndrome (obesity, insulin resistance, and so on) in rhesus monkeys and sheep (F1) that appeared to be exaggerated by postnatal overfeeding. 68, 69 In mice, maternal high-fat diet was reported to reduce insulin sensitivity also over two generations (F2) perpetuated through both maternal and paternal lineages. 70 Epigenetic findings on developmental priming for obesity and related disorder from studies in rodents The study of the agouti viable yellow mouse is an example of epigenetically induced obesity, where the agouti protein, normally coloring the fur yellow, is ectopically expressed and acts as an antagonist of the satiety peptide melanocortin-4 receptor in the hypothalamus. The ectopic expression is due to a hypomethylated active state of a transposon altering expression regulation. It provided an elegant example of that the maternal diet during pregnancy influences the epigenetic state of the offspringFdiet rich on methyl donors prevented transposon hypomethylation in the offspring and consequently obesity. 71 However, most research in this area has focused on the CpG methylation of key metabolic genes in response to maternal undernutrition. Protein restriction during pregnancy in rodents was found to reduce DNA methylation in promoters of certain key metabolic transcriptional regulators such as Ppar-a and the glucocorticoid receptor in liver, which was transmitted also to the second-generation (F2) progeny. 72, 73 This hypomethylation was proposed to in part be due to the reduction of DNMT1 activity, a feature observed in protein-restricted offspring. 74 Similarly, a liver X receptor involved in cholesterol and fatty acid metabolism was hypomethylated in rodent offspring from maternal protein restriction. 75 Folate supplementation has been used to restore methylation back to wild-type levels because folate is a methyl donor and has been linked to DNA methylation in a dose-dependent manner, as reviewed by Kim.
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The hypomethylation of Ppar-a after in utero exposure to protein restriction was rescued by folate supplementation to the postweaning young offspring. However, hypomethylation of other gene promoters remained or became more pronounced by folate supplementation signifying the specificity of epigenetic changes during development. 41 It also emphasizes the importance of in utero programming for later life phenotypes. The postnatal metabolic plasticity measured as 5mC and gene expression changes in rodent liver of Ppar-a, Gr, 11b-Hsd2 (inactivator of glucocorticoids) and Pepck by leptin administration was dependent on nutritional status in utero. 77 Maternal high-fat feeding has been shown to trigger alterations in offspring-sex-specific DNA methylation throughout the genome and alteration in expression, and CpG-specific methylation, of imprinted genes. 78 Accordingly, also maternal high-fat feeding may prime the offspring for obesity, as exemplified by altered DNA methylation of appetite regulatory genes: Rodent offspring exposed in utero to high-fat diet had promoter hypomethylation both globally and in dopamine transporter 3 (Dat), opioid receptor (Mor) and preproenkephalin (Penk), as well as long-term alterations in behavior and preference for foods high in fat and sugar. 79 Exposure to the DNA-hypomethylating bisphenol A in utero or neonatally was associated with higher body weight, 80 but methyl donors such as folic acid or genistein in the diet prevented this effect. 81 Hence, maternal methyl group supply, such as folate and choline, a maternal low-protein diet and a maternal high-fat diet in rodents throughout pregnancy has been shown to modify DNA methylation of some metabolic genes. However, it is unknown if the hypomethylation from protein-restricted diet simply represented a choline-deficient state, which by itself creates hypomethylation.
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Epigenetics in developmental priming for obesity and related disorder from studies in monkey and man Individuals exposed in utero to famine had 60 years later less DNA methylation of the imprinted IGF2 gene and the females had higher circulating lipid levels compared with their unexposed, same-sex siblings. 83, 84 This demonstrated that early-life environmental conditions can cause epigenetic changes in humans that persist throughout life. Recently, DNA methylation status in retinoid X receptor-a (positive transcription regulating region of RXRa) of neonates umbilical cord blood was found to be greater in those neonates that prospectively developed greater fat mass at 9 years of age, consistent with lower Rxra expression in )
. Several rodent studies have demonstrated that early exposure to hyperglycemia results in long-lasting histone modifications that can induce diabetic complications, through H3K4 methylation by the histone lysine methyltransferase SET7 (reviewed by Pirola et al. 87 ). Also, primates exposed in utero to high-fat diet showed non-alcoholic fatty liver disease and hyperacetylation of hepatic fetal H3K14 and a depletion in HDAC1 activity. These histone alterations were linked to changes in the expression of key genes involved in hepatic metabolism and a circadian clock regulator, neuronal PAS domain protein 2.
88

Epigenetic regulation of circadian rhythms
Circadian rhythms are those that approximate B24-h cycles that coincide with the day-night cycle. Normally, most physiological functions (energy homeostasis, thermogenesis, hunger-satiety, sleep, and so on) have a circadian rhythm. 89 These rhythms are regulated by a set of transcription factors (clock genes) that interact and thereby generate cyclic feedback loops. The clock system is influenced by light and other external stimuli including temperature and food intake. 90 Histone acetylation and deacetylation are central in the regulatory processes that generate the circadian oscillations in gene expression because the clock genes have endogenous histone acetyl transferase or HDAC activity, or interact with other histone acetyl transferases and HDACs. 91 Furthermore, CpG methylation may be involved in regulating the circadian oscillations since over a hundred DNA methylation sites oscillate synchronic with the cell cycle, 92 and the cell cycle is often regulated by the circadian clock. 93 The regulatory regions of circadian genes are enriched in CpG motifs compared with other genes. 94 Hence, poorly adapted behavior or lifestyle and desynchronized cues may disturb the epigenetic regulation of rhythmic gene expression and influence various physiological functions. The clock genes orchestrate rhythmic metabolic processes, such as glucose and lipid homeostasis. 95, 96 Hormones such as insulin, glucagon, adiponectin, leptin, ghrelin as well as many nuclear receptors involved in lipid and glucose metabolism display circadian changes in expression. 97 In utero exposure to maternal high-fat nutrition has been shown to upregulate the expression of fetal hepatic circadian-associated neuronal PAS domain protein 2, at least in part through hyperacetylation of histone H3 at lysine 14.
98
Transgenerational inheritance of epigenetic patterns
In addition to developmental priming through exposure to an altered in utero environment perpetuating the disease risk through epigenomic somatic alterations, there are also examples of proposed transmission through the germ-line of for example glucose metabolism (for review, see Gluckman and Hanson 64 ). Importantly, not only maternal but also certain paternal environmental exposure might induce epigenetic modifications. The findings supporting true transgenerational inheritance (F3) include altered glucose metabolism in F3 descending from rats (F0) on protein-restricted diet, 99 and increased female body size in F3 from F0 mice on maternal high-fat diet, an effect that was perpetuated paternally. 100 In man, information from prepubertal nutritional state has been reported to be transmitted through the germ-line affecting cardiovascular and diabetes mortality two generations later (F2). [101] [102] [103] Hence, it is possible that transgenerational inheritance of induced epigenetic modifications could contribute to obesity risk. However, apparent transgenerational epigenetic inheritance needs to be differentiated from non-germ-line environmental effects, as exemplified by poor maternal behavior inducing epigenetically based stress in the offspring and subsequent poor maternal behavior in the grown-up offspring, 104 resulting in a perpetuation or amplification of epigenetic alterations in the F2 generation or later that may appear as transgenerational. The agouti viable yellow mouse is one of few mammals for which the epigenetic modification behind transgenerational inheritance is known. 105 
Conclusions
Epigenetic regulation of chromatin is dynamic and enables control over gene expression for the cell to respond to various signaling pathways and environmental stimuli. Thus, methylation of DNA, modifications of the histones, small RNAs and regulation of numerous DNA-binding proteins participate to perpetuate the chromatin conformation that determines which genes will be transcriptionally competent in specific cell types. 106 Epigenetic marks can be stochastic or induced by environment, reversible or stable, transmitted mitotically, and possibly through the germ-line. There is substantial evidence demonstrating that epigenetic mechanisms have a role in the regulation of adipogenesis and glucose homeostasis. Suboptimal maternal (and perhaps, paternal) nutrition has been demonstrated to contribute to a particular epigenotype and thereby developmental metabolic priming of the exposed offspring. However, currently we have a limited ability to propose specific environmental exposures or drug targets, which might influence epigenetic mechanisms that might contribute to obesity at the population level. 50 Significantly more knowledge on epigenetic regulation of obesity and related disorder will probably be generated within the near future.
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